Benzinga | Oct 23, 2020 06:04AM EDT

Guggenheim Initiates Coverage On Axonics Modulation Tech with Buy Rating, Announces Price Target of $77

Guggenheim initiates coverage on Axonics Modulation Tech (NASDAQ:AXNX) with a Buy rating and announces Price Target of $77.